Febarbamate

Febarbamate

Clinical data
Other names	MS-543
ATC code	M03BA05 (WHO)
Identifiers
IUPAC name [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3- diazinan-1-yl)propan-2-yl] carbamate
CAS Number	13246-02-1^Y
PubChem CID	25803
ChemSpider	24039^Y
UNII	5Z48ONN38P
KEGG	D07275^Y
ChEMBL	ChEMBL2104283^N
CompTox Dashboard (EPA)	DTXSID40864380
ECHA InfoCard	100.032.919
Chemical and physical data
Formula	C20H27N3O6
Molar mass	405.451 g·mol^−1
3D model (JSmol)	Interactive image
SMILES C1(=O)NC(C(C(=O)N1CC(OC(=O)N)COCCCC)(C2=CC=CC=C2)CC)=O
InChI InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)^Y Key:QHZQILHUJDRDAI-UHFFFAOYSA-N^Y
^NY (what is this?)  (verify)

Febarbamate (INN; Solium, Tymium), also known as phenobamate, is an anxiolytic and tranquilizer of the barbiturate and carbamate families which is used in Europe by itself and as part of a combination drug formulation called tetrabamate.^[1][2][3][4]

See also

• Difebarbamate

References

1. World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
2. Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 427. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
3. Gentili E (March 1972). "[Therapeutic effects of a new psycholeptic agent (febarbamate, Solium) in pediatrics]". Minerva Medica (in Italian). 63 (18): 1058–60. PMID 5016064.
4. Morton I, Hall JM (1999). Concise dictionary of pharmacological agents: properties and synonyms. Springer. p. 118. ISBN 978-0-7514-0499-9. Retrieved 26 November 2011.